TPO and autoimmune thyroid disease: If future studies confirm a pathogenic role for anti-TPO antibodies, immunomodulatory interventions—such as B-cell depletion therapies—could be considered in select patients with progressive arteriopathy and serological evidence of thyroid autoimmunity.